Early-Phase Trials of Cellular and Gene Therapies This presentation focuses on issues that IND sponsors typically consider when developing an early-phase clinical trial; reviews the clinical risks associated with cellular and gene therapy products; and discusses some considerations for clinical protocol design that are relevant to these products. (Javascript is required to view Mediasite content)